Day: June 30, 2022
HALIFAX, Nova Scotia, June 29, 2022 (GLOBE NEWSWIRE) — MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended April 30, 2022.
Profit and Loss HighlightsRevenue: The Company recorded revenues in Q3 FY2022 of $323,925 compared to $64,631 for the same period last year. The increase in revenue in comparison with Q3 FY2021 was due to higher sales in for its Miriad®, Multiplo® and Reveal® product lines.
Gross Profit: The Company recorded a gross profit in Q3 FY2022 of $96,598 compared to $85,590 in Q2 FY2022 or compared to $30,884 for the same period last year.
Operating expenses: The Company recorded for this quarter operating expenses of $392,488 compared to $445,201 in Q2 FY2022 and compared to $233,300 in Q3 FY2021.
Net (loss) income: The Company recorded a net loss of $411,067 compared...